CanadaBuys #AB-2026-05265

Specialized Biochemical and Wet Lab Services for Alzheimer’s Disease Research

This opportunity involves the University of Calgary seeking specialized biochemical and wet lab services for Alzheimer’s disease research. - Government Buyer: - University of Calgary - OEMs and Vendors: - Amira Medical Technologies Inc. (specializing in diagnostic methods for Alzheimer’s Disease and protein misfolding disorders) - Products/Services Requested: - Biochemical and wet lab services utilizing proprietary spectral confocal microscopy - Analysis of metal-enriched amyloid samples generated by a university research project - No specific products or part numbers are listed; the focus is on specialized diagnostic services - Unique or Notable Requirements: - Use of Amira’s proprietary spectral analysis method for early detection of Alzheimer’s disease - Services are tied to the UCalgary/CABHI Investment Agreement IGNITE-2-00692 - Contract duration is one year, with a possible one-year renewal option subject to funding - Amira’s unique technology positions them as the only qualified provider for this requirement

Description

The University of Calgary intends to award a service contract to Amira Medical Technologies for biochemical and wet lab services related to diagnostic methods for Alzheimer's Disease and other protein misfolding disorders using spectral confocal microscopy. The contract involves extending Amira's existing spectral test knowledge to metal-enriched amyloid generated through UCalgary's research project. The spectral analysis method is proprietary to Amira, making them uniquely qualified for this work. The agreement is intended for one year with a potential one-year renewal option subject to future funding availability.

View original listing